Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Primary biliary cholangitis: A tale of epigenetically-induced secretory failure?
Pedro M. Rodrigues, María J. Perugorria, Álvaro Santos‐Laso, et al.
Journal of Hepatology (2018) Vol. 69, Iss. 6, pp. 1371-1383
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Aliya Gulamhusein, Gideon M. Hirschfield
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 2, pp. 93-110
Closed Access | Times Cited: 239
Primary biliary cholangitis
Ana Lleò, Giu-Qiang Wang, M. Eric Gershwin, et al.
The Lancet (2020) Vol. 396, Iss. 10266, pp. 1915-1926
Closed Access | Times Cited: 178
The challenges of primary biliary cholangitis: What is new and what needs to be done
Benedetta Terziroli Beretta‐Piccoli, Giorgina Mieli‐Vergani, Diego Vergani, et al.
Journal of Autoimmunity (2019) Vol. 105, pp. 102328-102328
Open Access | Times Cited: 106
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation
Ibone Labiano, Aloña Agirre‐Lizaso, Paula Olaizola, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 991-1004
Open Access | Times Cited: 47
Periodontitis increases the risk of gastrointestinal dysfunction: an update on the plausible pathogenic molecular mechanisms
Sayantan Mukherjee, Aditi Chopra, Shaswata Karmakar, et al.
Critical Reviews in Microbiology (2024), pp. 1-31
Open Access | Times Cited: 12
UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications
Daniel Cabrera, Juan Pablo Arab, Marco Arrese
Handbook of experimental pharmacology (2019), pp. 237-264
Closed Access | Times Cited: 73
Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis?
Marlyn J. Mayo
Hepatology (2022) Vol. 76, Iss. 2, pp. 518-531
Closed Access | Times Cited: 35
The structural basis of the pH-homeostasis mediated by the Cl−/HCO3− exchanger, AE2
Qing Zhang, Liyan Jian, Deqiang Yao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Reasons why women are more likely to develop primary biliary cholangitis
Ma Di, Jiaxuan Ma, Chun‐Mei Zhao, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e25634-e25634
Open Access | Times Cited: 6
The Role of Epigenetics in Primary Biliary Cholangitis
Alessio Gerussi, Elvezia Maria Paraboschi, Claudio Cappadona, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4873-4873
Open Access | Times Cited: 19
Primary biliary cholangitis: pathogenic mechanisms
Jesús Prìeto, Jesús M. Bañales, Juan Francisco Medina Gallardo
Current Opinion in Gastroenterology (2020) Vol. 37, Iss. 2, pp. 91-98
Open Access | Times Cited: 31
MicroRNA-34a Promotes EMT and Liver Fibrosis in Primary Biliary Cholangitis by Regulating TGF-β1/smad Pathway
Ying Pan, Jing Wang, Lan He, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 25
The genetic architecture of primary biliary cholangitis
Alessio Gerussi, Marco Carbone, Christophe Corpechot, et al.
European Journal of Medical Genetics (2021) Vol. 64, Iss. 9, pp. 104292-104292
Closed Access | Times Cited: 25
An Integrated Pathogenetic Model of Primary Biliary Cholangitis
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki
Livers (2025) Vol. 5, Iss. 2, pp. 15-15
Open Access
The immunobiology of female predominance in primary biliary cholangitis
Alessio Gerussi, Laura Cristoferi, Marco Carbone, et al.
Journal of Autoimmunity (2018) Vol. 95, pp. 124-132
Closed Access | Times Cited: 31
MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets
Chen Huang, Xian Xing, Xinyu Xiang, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 130, pp. 110558-110558
Open Access | Times Cited: 25
New Therapeutic Targets in Autoimmune Cholangiopathies
Alessio Gerussi, Martina De Luca, Laura Cristoferi, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 24
S-adenosyl-L-methionine (SAMe) halts the autoimmune response in patients with primary biliary cholangitis (PBC) via antioxidant and S-glutathionylation processes in cholangiocytes
Ewa Kilańczyk, Jesús M. Bañales, Ewa Wunsch, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 11, pp. 165895-165895
Open Access | Times Cited: 23
Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis
Ruiling Chen, Ruqi Tang, Xiong Ma, et al.
Clinics in Liver Disease (2022) Vol. 26, Iss. 4, pp. 583-611
Open Access | Times Cited: 14
New treatments/targets for primary biliary cholangitis
Christophe Corpechot, Raoul Poupon, Olivier Chazouillères
JHEP Reports (2019) Vol. 1, Iss. 3, pp. 203-213
Open Access | Times Cited: 22
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets
Marco Carbone, Chiara Milani, Alessio Gerussi, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 4, pp. 965-966
Open Access | Times Cited: 19
The Salivary Microbiota of Patients With Primary Biliary Cholangitis Is Distinctive and Pathogenic
Longxian Lv, Huiyong Jiang, Xiaoxiao Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
Exploring the Pathogenesis of Autoimmune Liver Diseases from the Heterogeneity of Target Cells
Zi-Xuan Qiu, Linxiang Huang, Xiaoxiao Wang, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Primary biliary cholangitis: primary autoimmune disease or primary secretory defect
Annarosa Floreani, Daniela Gabbia, Sara De Martin
Expert Review of Gastroenterology & Hepatology (2023) Vol. 17, Iss. 9, pp. 863-870
Closed Access | Times Cited: 6
Roles of Trained Immunity in the Pathogenesis of Cholangiopathies: A Therapeutic Target
Chao Yan, Stephane Koda, Jing Wu, et al.
Hepatology (2020) Vol. 72, Iss. 5, pp. 1838-1850
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top